Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke

Journal of Pediatrics

Volumn 164, Issue 3, 2014, Pages

  Benders, Manon J ^a   Van Der Aa, Niek E ^a   Roks, Maurice ^a   Van Straaten, Henrica L ^b   Isgum, Ivana ^c   Viergever, Max A ^c   Groenendaal, Floris ^a,c   De Vries, Linda S ^a   Van Bel, Frank ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Isala Hospital Zwolle   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BRAIN GROWTH; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN SIZE; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; DRUG MEGADOSE; DRUG SAFETY; ERYTHROCYTE COUNT; FEASIBILITY STUDY; FEMALE; GESTATIONAL AGE; HEART HEMODYNAMICS; HEART RATE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; LEUKOCYTE COUNT; NEUROIMAGING; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; SEIZURE; SHORT COURSE THERAPY; THROMBOCYTE COUNT;

BLOOD CELL COUNT; BRAIN ISCHEMIA; CEREBRAL PALSY; ERYTHROPOIETIN; FEASIBILITY STUDIES; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; INFANT, NEWBORN; MAGNETIC RESONANCE IMAGING; MALE; MATCHED-PAIR ANALYSIS; NEUROPROTECTIVE AGENTS; RECOMBINANT PROTEINS; SEIZURES; STROKE;

EID: 84894293541     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.10.084     Document Type: Article

References (39)

1. J.K. Lynch, and K.B. Nelson Epidemiology of perinatal stroke Curr Opin Pediatr 13 2001 499 505
2. S. Schulzke, P. Weber, J. Luetschg, and H. Fahnenstich Incidence and diagnosis of unilateral arterial cerebral infarction in newborn infants J Perinat Med 33 2005 170 175
3. J. Lee, L.A. Croen, G. Lindan, K.B. Nash, C.K. Yoshida, and D.M. Ferriero et al. Predictors of outcome in perinatal arterial stroke: a population-based study Ann Neurol 58 2005 303 308
4. Z.Z. Chong, J.Q. Kang, and K. Maiese Erythropoietin fosters both intrinsic and extrinsic neuroprotection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways Br J Pharmacol 138 2003 1107 1118
5. Y. Sun, J.W. Calvert, and J.H. Zhang Neonatal hypoxia/ischemia is associated with decreased inflammatory mediators after erythropoietin administration Stroke 36 2005 1672 1678
6. A. Sola, M. Rogido, B.H. Lee, T. Genetta, and T.C. Wen Erythropoietin after focal cerebral ischemia activates the Janus kinase-signal transducer and activator of transcription signaling pathway and improves brain injury in postnatal day 7 rats Pediatr Res 57 2005 481 487
7. A. Sola, T.C. Wen, E.G. Hammrick, and D.M. Ferriero Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 57 2005 110R 117R
8. F.F. Gonzalez, R. Abel, C.R. Almli, D. Mu, M. Wendland, and D.M. Ferriero Erythropoietin sustains cognitive function and brain volume after neonatal stroke Dev Neurosci 31 2009 403 411
9. P. Villa, J. van Beek, A.K. Larsen, J. Gerwien, S. Christensen, and A. Cerami et al. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivates J Cereb Flow Metab 27 2007 552 563
10. H. Ehrenreich, M. Hasselblatt, C. Dembowski, L. Cepek, P. Lewczuk, and M. Stiefel et al. Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 2002 495 505
11. M. Iwai, R.A. Stetler, J. Xing, X. Hu, Y. Gao, and W. Zhang et al. Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury Stroke 41 2010 1032 1037
12. S.E. Juul, R.J. McPherson, L.A. Bauer, K.J. Ledbetter, and C.A. Gleason A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety Pediatrics 122 2012 383 391
13. US Food and Drug Administration. Amgen. Epogen (epoietin alfa) for injection. 2005. www.fda.gov/medwatch/safety/2008/epo-DHCP-03102008.pdf. Accessed June 17, 2008.
14. C. Wiessner, P.R. Allegrini, D. Ekatodramis, U.R. Jewell, T. Stallmach, and M. Gassmann Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin J Cereb blood Flow Metab 21 2001 857 864
15. N.E. van der Aa, E.D. Porsius, J. Hendrikse, B.J.M. van Kooij, M.J.N.L. Benders, and L.S. De Vries et al. Changes in carotid blood flow after unilateral perinatal arterial ischemic stroke Pediatr Res 72 2012 50 56
16. F. Groenendaal, M.J. Benders, and L.S. de Vries Pre-Wallerian degeneration in the neonatal brain following perinatal cerebral hypoxia-ischemia demonstrated with MRI Semin Perinat 30 2006 146 150
17. P.J. Stohlawetz, L. Dzirlo, N. Hergovich, E. Lackner, C. Mensik, and H. Eichler et al. Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans Blood 95 2000 2983 2989
18. E. Dessypris, S.E. Graber, S.B. Krantz, and W.J. Stone Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo Blood 72 1988 2060 2062
19. J.M. Koenig, and R.D. Christensen Effect of erythropoietin on granulocytopoiesis: in vitro and in vivo studies in weanling rats Pediatr Res 27 1990 583 587
20. R.D. Christensen, K.W. Liechty, J.M. Koenig, K.R. Schibler, and R.K. Ohls Administration of erythropoietin to newborn rats results in diminished neutrophil production Blood 78 1991 1241 1246
21. R.F. Maier, M. Obladen, P. Scigalla, O. Linderkamp, G. Duc, and G. Hieronimi et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants N Engl J Med 330 1994 1173 1180
22. J.C. Fauchere, C. Dame, R. Vontheim, B. Koller, S. Arri, and M. Wolf et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants Pediatrics 122 2008 375 382
23. H. Elmahdy, A.R. El-Mashad, H. El-Bahrawy, T. El-Gohary, A. El-Barbary, and H. Aly Human recombinant erythrooietin in asphyxia neonatorum: pilot trial Pediatrics 125 2010 e1135 e1142
24. C. Zhu, W. Kang, F. Xu, X. Cheng, Z. Zhang, and L. Jia et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy Pediatrics 124 2009 e218 e226
25. Y.W. Wu, L.A. Bauer, R.A. Ballard, D.M. Ferriero, D.V. Glidden, and D.E. Mayock et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics Pediatrics 130 2012 e683 e691
26. G. Gunther, R. Junker, R. Strater, R. Schobess, K. Kurnik, C. Heller Childhood Stroke Study Group Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors [erratum in: Stroke 2001;32:279] Stroke 31 2000 2437 2441
27. M.L. Brines, P. Gherezzi, S. Keenan, D. Agnello, N.C. de Lanerolle, and C. Cerami et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA 97 2000 10526 10531
28. M.A. Van der Kooij, F. Groenendaal, A. Kavelaars, C.J. Heijnen, and F. Van Bel Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia Brain Res Rev 59 2008 22 33
29. B.A. Kellert, R.J. McPherson, and S.E. Juul A comparison of high-dose recombinant erythropoietin treatment regimens in brain-injured neonatal rats Pediatr Res 61 2007 451 455
30. F.F. Gonzalez, P. McQuillen, D. Mu, Y. Chang, M. Wendland, and Z. Vexler et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke Dev Neurosci 29 2007 321 330
31. H. Matsushita, M.V. Johnston, M.S. Lange, and M.A. Wilson Protective effect of erythropoietin in neonatal hypoxic ischemia in mice Neuroreport 14 2003 1757 1761
32. T. Wen, M. Rogido, H. Peng, T. Genetta, J. Moore, and A. Sola Gender differences in long-term beneficial effects of erythropoietin given after neonatal stroke in postnatal day-7 rats Neuroscience 139 2006 803 811
33. X. Fan, C.J. Heijnen, M.A. van der Kooij, F. Groenendaal, and F. Van Bel Beneficial effect of erytrhopioetin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice Pediatr Res 69 2011 1 2
34. M. Keller, J. Yang, E. Griesmaier, A. Gorna, G. Sarkozy, and M. Urbanek et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice Neurobiol Dis 61 2007 357 366
35. S.T. Lee, K. Chu, D.I. Sinn, K.H. Jung, E.H. Kim, and S.J. Kim et al. Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage J Neurochem 96 2006 1728 1739
36. L. Wang, Z. Zhang, Y. Wang, R. Zhang, and M. Chopp Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 35 2004 1732 1737
37. T. Shingo, S.T. Sorokan, T. Shimazaki, and S. Weiss Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells J Neurosci 21 2001 9733 9743
38. F.F. Gonzalez, A. Fang, and D.M. Ferriero Is erythropoietin the answer? Pediatr Res 69 2011 2 3
39. A. Weber, M. Dzietko, M. Berns, U. Felderhoff-Mueser, U. Heinenmann, and R.F. Maier et al. Neuronal damage after moderate hypoxia and erythropoietin Neurobiol Dis 20 2005 594 600